Skip to main content
Vital Chemtech Limited logo

Vital Chemtech Limited — Investor Relations & Filings

Ticker · VITAL ISIN · INE0L4K01016 LEI · 335800ILC78PRID95F06 National Stock Exchange of India Manufacturing
Open in API
Filings indexed 151 across all filing types
Latest filing 2025-10-11 Regulatory Filings
Country IN India
Listing National Stock Exchange of India VITAL

About Vital Chemtech Limited

https://www.vitalgroup.co.in/

Vital Chemtech Limited specializes in the production of phosphorus derivatives and specialty chemicals. The core product range includes Phosphorus Trichloride, Phosphorus Oxychloride, and Phosphorus Pentachloride, which function as essential intermediates for the agrochemical, pharmaceutical, and polymer sectors. The organization operates advanced manufacturing facilities equipped with modern technology to ensure high-purity output and adherence to international quality standards. Its technical capabilities extend to the development of customized chemical solutions and process optimization through dedicated research and development. By focusing on efficient production cycles and technical expertise, the company supports diverse industrial applications requiring precise chemical formulations and reliable supply chain integration.

Recent filings

Filing Released Lang Actions
Updates
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, informing the stock exchange about the company being granted BIS registration for a product. It is a regulatory announcement about a compliance or certification update, not a financial report or detailed filing. The document is short (1721 characters) and serves as a notification to the stock exchange rather than a report or detailed disclosure. It does not contain financial data, management changes, voting results, or other report types. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-10-11 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate submitted under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, confirming compliance for the quarter ended September 30, 2025. It is addressed to the National Stock Exchange of India and signed by the Chairman & Managing Director. The document is short (1546 characters) and primarily serves as a compliance certificate rather than containing financial data or detailed report content. According to the Certification Rule, such officer certifications or compliance confirmations should be classified as Regulatory Filings (RNS).
2025-10-09 English
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
Regulatory Filings Classification · 95% confidence The document is a certificate addressed to the National Stock Exchange of India regarding the non-applicability of certain regulatory provisions (Regulation 27(2) of SEBI Listing Obligations) for the quarter ended September 30, 2025. It states that the company is exempt from filing quarterly/half yearly/yearly Corporate Governance Reports due to its listing on the Emerge Platform. The document is a formal regulatory communication or certification rather than a full report or financial statement. It does not contain financial data or detailed report content but serves as a compliance notification or attestation. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory announcement and certification rather than a full report or announcement of voting results, management changes, or other specific categories.
2025-10-09 English
Outcome of Board Meeting
Board/Management Information Classification · 100% confidence The document is a formal communication addressed to the National Stock Exchange of India regarding the outcome of a Board meeting held on October 7, 2025. It announces the appointment of Mr. Vipul Bhatt as Chief Financial Officer, including detailed information about his profile and terms of appointment. The document references compliance with SEBI regulations and includes an annexure with appointment details. There are no financial statements or comprehensive financial data presented, nor is this a full report or earnings release. The content clearly pertains to a management change announcement. Therefore, the document fits the category of Board/Management Information (MANG). The document length is under 5,000 characters, but it is not merely an announcement of a report publication; it is the actual announcement of a management appointment.
2025-10-08 English
Appointment
Board/Management Information Classification · 95% confidence The document is a formal communication addressed to the National Stock Exchange of India Limited regarding the outcome of a Board meeting held on October 7, 2025. It announces the appointment of Mr. Vipul Bhatt as Chief Financial Officer of the company, Vital Chemtech Limited. The document references compliance with SEBI regulations and includes an annexure with details about the appointment. There are no financial statements, earnings data, or detailed reports included. The document is primarily an announcement of a board management change rather than a full report or financial disclosure. Therefore, it fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and it is not a report publication announcement or certification. Hence, the classification is MANG with high confidence.
2025-10-07 English
Appointment
Regulatory Filings
2025-09-30 English

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.